GB0116643D0 - Antiviral compounds - Google Patents

Antiviral compounds

Info

Publication number
GB0116643D0
GB0116643D0 GBGB0116643.8A GB0116643A GB0116643D0 GB 0116643 D0 GB0116643 D0 GB 0116643D0 GB 0116643 A GB0116643 A GB 0116643A GB 0116643 D0 GB0116643 D0 GB 0116643D0
Authority
GB
United Kingdom
Prior art keywords
antiviral compounds
antiviral
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0116643.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virogen Ltd
Original Assignee
Virogen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virogen Ltd filed Critical Virogen Ltd
Priority to GBGB0116643.8A priority Critical patent/GB0116643D0/en
Publication of GB0116643D0 publication Critical patent/GB0116643D0/en
Priority to PCT/EP2002/007632 priority patent/WO2003006017A2/en
Priority to AU2002325312A priority patent/AU2002325312A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0116643.8A 2001-07-09 2001-07-09 Antiviral compounds Ceased GB0116643D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0116643.8A GB0116643D0 (en) 2001-07-09 2001-07-09 Antiviral compounds
PCT/EP2002/007632 WO2003006017A2 (en) 2001-07-09 2002-07-08 Use of certain castanospermine esters in the treatment of influenza virus infections
AU2002325312A AU2002325312A1 (en) 2001-07-09 2002-07-08 Use of certain castanospermine esters in the treatment of influenza virus infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0116643.8A GB0116643D0 (en) 2001-07-09 2001-07-09 Antiviral compounds

Publications (1)

Publication Number Publication Date
GB0116643D0 true GB0116643D0 (en) 2001-08-29

Family

ID=9918105

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0116643.8A Ceased GB0116643D0 (en) 2001-07-09 2001-07-09 Antiviral compounds

Country Status (3)

Country Link
AU (1) AU2002325312A1 (en)
GB (1) GB0116643D0 (en)
WO (1) WO2003006017A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018072298A2 (en) 2016-05-02 2019-02-12 Florida State University Research Foundation, Inc. treatment of Zika virus infections using alpha-glucosidase inhibitors
US20220257604A1 (en) * 2019-03-08 2022-08-18 University Of Virginia Patent Foundation Compositions and methods for modulating viral infections by regulating glucosylceramides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027433D0 (en) * 1990-12-18 1991-02-06 Merrell Dow Pharma Anti-herpes castanospermine esters
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds

Also Published As

Publication number Publication date
WO2003006017A2 (en) 2003-01-23
AU2002325312A1 (en) 2003-01-29
WO2003006017A3 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
AU2002349297A8 (en) Statin-like compounds
GB0101996D0 (en) Organtic compounds
GB0112324D0 (en) Compounds
GB0102668D0 (en) Compounds
GB0108102D0 (en) Compounds
HUP0400345A3 (en) Antiviral phosphono-pyrimidine derivatives
GB0102673D0 (en) Compounds
GB0119474D0 (en) Compounds
GB0102665D0 (en) Compounds
GB0119472D0 (en) Compounds
EP1458669A4 (en) Neuorologically-active compounds
GB0116643D0 (en) Antiviral compounds
GB0115178D0 (en) Compounds
GB0118364D0 (en) Compounds
GB0120344D0 (en) Compounds
GB0119473D0 (en) Compounds
GB0108097D0 (en) Compounds
GB0119688D0 (en) Antiviral compounds
AUPR520201A0 (en) Antiviral compounds
GB0105098D0 (en) Compounds
GB0106673D0 (en) Compounds
GB0114291D0 (en) Compounds
GB0120323D0 (en) Compounds
GB0103314D0 (en) Compounds
GB0120324D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)